Robert Klitzman, MD, professor of psychiatry, addresses the ethical and health concerns that must be considered in tackling the obesity epidemic and broader public health challenges.
A Columbia study shows a simple smell test and memory exam can predict cognitive decline as accurately as costly brain imaging, offering a more affordable and accessible way to assess dementia.
“With some mental health conditions, in particular, psychotic disorders, I think there is a genetic or a biological component that can interact with a life stressor,” says Dr. Jeffrey Cohen.
Dr. Michael Grunebaum says that in his clinical trials, many patients don’t find that the drug relieves anxiety. “Ketamine is just a really distinct, weird, spacey feeling,” he says.
Dr. John Mann, whose parents escaped the Warsaw Ghetto and were liberated at the Bergen-Belsen concentration camp, said the celebration highlighted “continuity and survival itself.”
A discussion with Dr. Deborah Cabaniss and Dr. Yael Holoshitz about their new book Different Patients, Different Therapies: Optimizing Treatment Using Differential Psychotherapuetics.
Dr. Kimberly Mangla’s research has shown that suicide is an underrecognized risk among new mothers, driven most often by depression, substance use disorders, or intimate partner violence.
Compared with the one-fifth of participants whose diet had the lowest glycemic index, those with the highest were 11 percent more likely to have insomnia.
“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.